Search Clinical Trials
Home >  Clinical Trials & Research >  Search Clinical Trials
Print

Clinical Trials & Research

Search Clinical Trials

Clinical Trials

New Search
Title   A Phase III Study of MPDL3280A (Anti-PD-L1 Antibody) in Combination With Carboplatin + Paclitaxel With or Without Bevacizumab in Patients With Stage IV Non-squamous Non-small Cell Lung Cancer [IMpower 150]
Disease/Condition   Lung Cancer
Description  

Click here for more information

Eligibility Criteria   Ages Eligible for Study: 18 Years and older Genders Eligible for Study: Both Accepts Healthy Volunteers: No Click here for eligibility requirements
Principal Investigator   Haiying Cheng, MD
Contact Name   Karen Fehn
Phone   (718) 405-8446
Contact Email   CPDMUtrialinfo@montefiore.org
Protocol Number   IRB# 15-06-221-01
Inclusion/Notes   This information was obtained from ClinicalTrials.gov.
Status   Enrolling
Adult Clinical Trial   Yes
Pediatric Clinical Trial   No